ALK and neoplasm: When DCTN1 undergoes a gene fusion with ALK, DCTN1 is suspected to promote the dimerization of ALK and lead to the abnormal activation of the ALK kinase by transphosphorylation, thereby promoting the proliferation and survival of tumor cells (8).